A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia
Clinical trial NCT07223190 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07223190
- Sponsor
- Amgen
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-11
- Primary completion
- 2030-05-10
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.